Comparison of the Inhibition of Monoamine Oxidase and Butyrylcholinesterase Activities by Infusions from Green Tea and Some Citrus Peels
Open Access
- 5 August 2014
- journal article
- research article
- Published by Wiley in International Journal of Alzheimer's Disease
- Vol. 2014, 1-5
Abstract
This study sought to investigate the effect of infusions from green tea (Camellia sinensis) and some citrus peels [shaddock (Citrus maxima), grapefruit (Citrus paradisi), and orange (Citrus sinensis)] on key enzymes relevant to the management of neurodegenerative conditions [monoamine oxidase (MAO) and butyrylcholinesterase (BChE)]. The total phenol contents and antioxidant activities as typified by their 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) radicals scavenging abilities, ferric reducing antioxidant properties, and Fe2+chelating abilities were also investigated. Green tea had the highest total phenol (43.3 mg/g) and total flavonoid (16.4 mg/g) contents, when compared to orange [total phenol (19.6 mg/g), total flavonoid (6.5 mg/g)], shaddock [total phenol (16.3 mg/g), total flavonoid (5.2 mg/g)], and grapefruit [total phenol (17.7 mg/g), total flavonoid (5.9 mg/g)]. Orange (EC50= 1.78 mg/mL) had the highest MAO inhibitory ability, while green tea had the least MAO inhibitory ability (EC50= 2.56 mg/mL). Similarly, green tea had the least BChE inhibitory ability (EC50= 5.43 mg/mL) when compared to the citrus peels’ infusions. However, green tea infusions had the strongest highest ABTS radical scavenging ability, reducing power, and Fe2+chelating ability. The inhibition of MAO and BChE activities by the green tea and citrus peels infusions could make them good dietary means for the prevention/management of neurodegenerative conditions.Keywords
This publication has 32 references indexed in Scilit:
- Acetylcholinesterase Inhibitory, Antioxidant and Phytochemical Properties of Selected Medicinal Plants of the Lamiaceae FamilyMolecules, 2014
- New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing PropertiesJournal of Medicinal Chemistry, 2012
- Brain iron metabolism and its perturbation in neurological diseasesJournal of Neural Transmission, 2010
- Screening of Algerian Medicinal Plants for Acetylcholinesterase Inhibitory ActivityJournal of Biological Sciences, 2009
- Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy2009
- Oxidative Stress in Immature Brain after Traumatic Brain InjuryDevelopmental Neuroscience, 2006
- Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases.In vivoselective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletionJournal of Neurochemistry, 2005
- Determination of major anthocyanin pigments in Hellenic native grape varieties (Vitis vinifera sp.): association with antiradical activityJournal of Food Composition and Analysis, 2005
- Determination of the total phenolic, flavonoid and proline contents in Burkina Fasan honey, as well as their radical scavenging activityFood Chemistry, 2005
- An investigation into thee mechanism of citrateFE2+-dependent lipid peroxidationFree Radical Biology and Medicine, 1987